N-Zyme Biomedical

N-Zyme BiomedicalN-Zyme Biomedical
N-Zyme Biomedical

N-Zyme Biomedical

A biotechnology company focused on developing novel enzyme-based therapies for reflux disease.

Reddit“N-Zyme Biomedical Begins Phase 2 Trial of First Pepsin Inhibitor for Reflux Disease. What does this mean? Are…”
Website
DR 4.82021Active5Newark, United States
Rate
Advertise here

About

N-Zyme Biomedical is a clinical-stage biotechnology company developing first-in-class therapies that target pepsin, a key driver of tissue damage in reflux disease. The company's lead drug candidate, NZ-101, is currently in Phase 2 clinical trials for laryngopharyngeal reflux (LPR) and proton pump inhibitor (PPI)-refractory gastroesophageal reflux disease (GERD). N-Zyme Biomedical aims to transform the treatment of reflux disease by addressing its underlying causes rather than solely focusing on acid suppression.
HEADCOUNT
5
DOMAIN RATING
4.8
Comments
(1)
0 positive1 mixed0 negative
Reddit
r/LPRu/Many-Pineapple3576Jun 17, 2026Mixed

“N-Zyme Biomedical Begins Phase 2 Trial of First Pepsin Inhibitor for Reflux Disease. What does this mean? Are they closer to the drug?”

View on Reddit

Some comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.

Frequently asked

What does N-Zyme Biomedical do?

N-Zyme Biomedical is a clinical-stage biotechnology company developing first-in-class therapies that target pepsin, a key driver of tissue damage in reflux disease. The company's lead drug candidate, NZ-101, is currently in Phase 2 clinical trials for laryngopharyngeal reflux (LPR) and proton pump inhibitor (PPI)-refractory gastroesophageal reflux disease (GERD). N-Zyme Biomedical aims to transform the treatment of reflux disease by addressing its underlying causes rather than solely focusing on…

How much funding has N-Zyme Biomedical raised?

N-Zyme Biomedical has raised a total of $5M in funding. The most recent round on record is Series A.

Where is N-Zyme Biomedical headquartered?

N-Zyme Biomedical is headquartered in Newark, United States.

When was N-Zyme Biomedical founded?

N-Zyme Biomedical was founded in 2021.

What industry does N-Zyme Biomedical operate in?

N-Zyme Biomedical operates in Biotechnology, Pharmaceuticals, HealthTech, Biotech, MedTech, Drug Discovery.

How many employees does N-Zyme Biomedical have?

N-Zyme Biomedical has approximately 5 people on record.

What is N-Zyme Biomedical's revenue?

StartupHub estimates N-Zyme Biomedical's annual revenue at $503K (range $278K to $1.5M, 69% confidence), based on comparable companies in the sector.

What is N-Zyme Biomedical's valuation?

StartupHub estimates N-Zyme Biomedical's effective valuation at $18.3M (range $11.5M to $27.6M, 25% confidence), based on comparable companies in the sector.